Anifrolumab to treat a monogenic interferonopathy

Affiliations

• ¹ Division of Immunology, Allergy, and Rheumatology, Department of Pediatrics, University of California Los Angeles, Los Angeles, Calif.
• ² Division of Hematology and Oncology, Department of Pediatrics, University of California Los Angeles, Los Angeles, Calif; Miller Children's and Women's Hospital, Long Beach, Calif.
• ³ Division of Immunology, Allergy, and Rheumatology, Department of Pediatrics, University of California Los Angeles, Los Angeles, Calif; Department of Microbiology, Immunology, and Molecular Genetics, University of California Los Angeles, Los Angeles, Calif; Department of Human Genetics, University of California Los Angeles, Los Angeles, Calif. Electronic address: mbutte@mednet.ucla.edu.